Comparison of START participants on antiplatelet, tPA, or anticoagulant medication (n = 31) versus those not on those medications (n = 88).

<p>Comparison of START participants on antiplatelet, tPA, or anticoagulant medication (n = 31) versus those not on those medications (n = 88).</p>

Publication Details

Journal
Figshare
Published
2024-08-30
DOI
https://doi.org/10.1371/journal.pone.0308103.s006
Primary Topic
Antiplatelet Therapy and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of START participants on antiplatelet, tPA, or anticoagulant medication (n = 31) versus those not on those medications (n = 88).

Figshare
Antiplatelet Therapy and Cardiovascular Diseases
article

Comparison of START participants on antiplatelet, tPA, or anticoagulant medication (n = 31) versus those not on those medications (n = 88).

article en

Abstract

<p>Comparison of START participants on antiplatelet, tPA, or anticoagulant medication (n = 31) versus those not on those medications (n = 88).</p>

Figshare
Openalex Percentile: Top 52%
Antiplatelet Therapy and Cardiovascular Diseases
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comparison of START participants on antiplatelet, tPA, or anticoagulant medication (n = 31) versus those not on those medications (n = 88). · Figshare (2024) | TGRS Research Map | TGRS